Company intelligence / Profile preview

DAN Biotech

Cheonan, Chungcheongnam-do, South Korea
Ownership
Private
Development stage
Other
01

Overview

DanBiotech is a South Korean biotechnology company focused on the discovery and development of innovative therapeutic antibodies and recombinant proteins for oncology and inflammatory diseases. The company leverages its proprietary platform for high-affinity antibody selection and protein engineering to target immune checkpoints and pro-inflammatory cytokines. Their pipeline includes several pre-clinical candidates targeting PD-1/PD-L1 and VISTA for cancer immunotherapy, as well as treatments for autoimmune conditions like atopic dermatitis and rheumatoid arthritis. DanBiotech also provides specialized R&D services, including protein production and cell line development, to academic and industrial partners.

Therapeutic areas
OncologyImmunologyOphthalmologyDermatology
Modalities
Monoclonal antibodyRecombinant proteinCell therapySmall molecule
Industry
Biotech
02

Partnerships

Chungnam National UniversityKorea Research Institute of Bioscience and Biotechnology (KRIBB)

Beyond the preview

Go deeper on DAN Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DAN Biotech.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call